Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells

Background. In this study the effect of histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) on the energetic status and cardiomyogenic differentiation of human healthy and dilated myocardium-derived mesenchymal stromal cells (hmMSC) have been investigated. Methods. The hmMSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Miksiunas, Rokas, Rucinskas, Kestutis, Janusauskas, Vilius, Labeit, Siegfried, Bironaite, Daiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402340/
https://www.ncbi.nlm.nih.gov/pubmed/32650632
http://dx.doi.org/10.3390/ijms21144845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402340/
https://www.ncbi.nlm.nih.gov/pubmed/32650632
http://dx.doi.org/10.3390/ijms21144845

Ejemplares similares